Your session is about to expire
← Back to Search
Hybrid Contact Lens
SynergEyes A2 Hybrid Contact Lens for Astigmatism
N/A
Waitlist Available
Led By Paul Kusy, OD, MS, FAAO
Research Sponsored by SynergEyes, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This is a multicenter study to evaluate the clinical performance of the SynergEyes A2 lens in patients with refractive errors with or without astigmatism.
Eligible Conditions
- Astigmatism
- Refractive Errors
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Confirm current SynergEyes A2 lens design by evaluating clinical performance using objective and subjective parameters
Secondary outcome measures
Determine the best method for fitting the SynergEyes A2 hybrid contact lens
Trial Design
1Treatment groups
Experimental Treatment
Group I: SynergEyes A2 Hybrid Contact LensExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
SynergEyes, Inc.Lead Sponsor
2 Previous Clinical Trials
98 Total Patients Enrolled
Paul Kusy, OD, MS, FAAOPrincipal InvestigatorSynergEyes, Inc.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger